MyAverix Finance
SHG · Healthcare
Guangzhou Kingmed Diagnostics Group Co Ltd (603882)
Diagnostics & Research
Guangzhou Kingmed Diagnostics Group Co Ltd (603882) is listed on SHG in the Healthcare sector. Industry: Diagnostics & Research. As of 2026-03-29, reported market cap is $11.92B, P/E ratio is 18.00, net margin is -9.1%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 603882
Guangzhou Kingmed Diagnostics Group Co Ltd (603882) — FAQ
What is Guangzhou Kingmed Diagnostics Group Co Ltd's market cap?
Guangzhou Kingmed Diagnostics Group Co Ltd (603882) has a reported market cap of $11.92B (data as of 2026-03-29).
What is 603882's P/E ratio?
The price-to-earnings (P/E) ratio for Guangzhou Kingmed Diagnostics Group Co Ltd (603882) is 18.00 (data as of 2026-03-29).
Does Guangzhou Kingmed Diagnostics Group Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Guangzhou Kingmed Diagnostics Group Co Ltd (603882). Check the MyAverix Finance app for the latest dividend data.
What sector is Guangzhou Kingmed Diagnostics Group Co Ltd in?
Guangzhou Kingmed Diagnostics Group Co Ltd (603882) is classified in the Healthcare sector (Diagnostics & Research industry).
What exchange is 603882 listed on?
603882 is listed on SHG.
What is Guangzhou Kingmed Diagnostics Group Co Ltd's net margin?
Guangzhou Kingmed Diagnostics Group Co Ltd (603882) reports a net margin of -9.1% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.